<scp>TAK</scp>‐875, a <scp>GPR</scp>40/<scp>FFAR</scp>1 agonist, in combination with metformin prevents progression of diabetes and <scp>β</scp>‐cell dysfunction in <scp>Z</scp>ucker diabetic fatty rats - Concepedia

Concepedia

Publication | Open Access

<scp>TAK</scp>‐875, a <scp>GPR</scp>40/<scp>FFAR</scp>1 agonist, in combination with metformin prevents progression of diabetes and <scp>β</scp>‐cell dysfunction in <scp>Z</scp>ucker diabetic fatty rats

DOI Full Paper Access

36

Citations

43

References

2013

Year

Ryo Ito, Yoshiyuki Tsujihata, Matsuda-Nagasumi Kae, Ikuo Mori, Nobuyuki Negoro, Koji Takeuchi

British Journal of Pharmacology

Abstract

Our results indicate that combination therapy with TAK-875 and metformin could be a valuable strategy for glycaemic control and β-cell preservation in type 2 diabetes.

References

	Year	Citations

Page 1